JP2024524613A5 - - Google Patents
Info
- Publication number
- JP2024524613A5 JP2024524613A5 JP2024501118A JP2024501118A JP2024524613A5 JP 2024524613 A5 JP2024524613 A5 JP 2024524613A5 JP 2024501118 A JP2024501118 A JP 2024501118A JP 2024501118 A JP2024501118 A JP 2024501118A JP 2024524613 A5 JP2024524613 A5 JP 2024524613A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- optionally
- prodrug
- independently
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221915P | 2021-07-14 | 2021-07-14 | |
| US63/221,915 | 2021-07-14 | ||
| PCT/US2022/037196 WO2023288015A1 (en) | 2021-07-14 | 2022-07-14 | M6pr cell surface receptor binding compounds and conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524613A JP2024524613A (ja) | 2024-07-05 |
| JP2024524613A5 true JP2024524613A5 (https=) | 2025-07-23 |
Family
ID=82786881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501118A Pending JP2024524613A (ja) | 2021-07-14 | 2022-07-14 | Ｍ６ｐｒ細胞表面受容体結合化合物及びコンジュゲート |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240335544A1 (https=) |
| EP (1) | EP4370156A1 (https=) |
| JP (1) | JP2024524613A (https=) |
| CN (1) | CN117915956A (https=) |
| AU (1) | AU2022310346A1 (https=) |
| CA (1) | CA3226268A1 (https=) |
| WO (1) | WO2023288015A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4370157A1 (en) | 2021-07-14 | 2024-05-22 | Lycia Therapeutics, Inc. | Asgpr cell surface receptor binding compounds and conjugates |
| JP2026503462A (ja) | 2023-01-18 | 2026-01-29 | ライシア セラピューティクス， インコーポレイテッド | 自己抗体の分解のためのリソソーム標的化二官能性分子 |
| CN120835794A (zh) * | 2023-01-18 | 2025-10-24 | 利西亚治疗公司 | M6pr结合化合物和缀合物 |
| CN120882430A (zh) | 2023-01-18 | 2025-10-31 | 利西亚治疗公司 | 循环溶酶体靶向抗体缀合物 |
| WO2024182772A2 (en) * | 2023-03-02 | 2024-09-06 | Avilar Therapeutics, Inc. | Mannose 6-phosphate receptor binding compounds for the degradation of extracellular proteins |
| FR3149188A1 (fr) * | 2023-05-31 | 2024-12-06 | Nanomedsyn | Pro-ligands, conjugués comprenant lesdits pro-ligands et leurs utilisations pour des applications thérapeutiques |
| CN121548590A (zh) * | 2023-07-25 | 2026-02-17 | 深圳湾实验室 | 一种多特异性结合蛋白及其应用 |
| WO2026015664A1 (en) | 2024-07-10 | 2026-01-15 | Lycia Therapeutics, Inc. | Cycling lysosomal targeting chimeras targeting immunoglobulin e (ige) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05000511A (es) | 2001-07-12 | 2005-09-30 | Jefferson Foote | Anticuepros super humanizados. |
| DK1791565T3 (en) | 2004-09-23 | 2016-08-01 | Genentech Inc | Cysteingensplejsede antibodies and conjugates |
| WO2015143091A1 (en) | 2014-03-19 | 2015-09-24 | Genzyme Corporation | Site-specific glycoengineering of targeting moieties |
| CA3205824A1 (en) | 2014-10-09 | 2016-04-14 | Genzyme Corporation | Glycoengineered antibody drug conjugates |
| FR3041345B1 (fr) * | 2015-09-18 | 2019-06-14 | Nanomedsyn | Composes polysaccharides multi-fonctionnalises et leur utilisation pour cibler le recepteur du mannose 6-phosphate cation-independant |
| AU2019404061A1 (en) | 2018-12-19 | 2021-07-22 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules for lysosomal targeting and related compositions and methods |
| US20230051872A1 (en) | 2019-03-22 | 2023-02-16 | Reflexion Pharmaceuticals, Inc. | Multivalent D-Peptidic Compounds for Target Proteins |
| KR20220044612A (ko) | 2019-03-22 | 2022-04-08 | 리플렉시온 파마슈티컬스, 인크. | Vegf에 대한 d-펩티드성 화합물 |
| US20230158155A1 (en) | 2020-01-10 | 2023-05-25 | Lycia Therapeutics, Inc. | Cell Surface Receptor Binding Compounds and Conjugates |
| EP4171658A4 (en) * | 2020-06-24 | 2025-04-09 | Lycia Therapeutics, Inc. | Modified viral compositions for viral transduction |
| EP4171659A4 (en) * | 2020-06-24 | 2025-04-09 | Lycia Therapeutics, Inc. | BIFUNCTIONAL BRIDGE COMPOSITIONS FOR VIRAL TRANSDUCTION |
-
2022
- 2022-07-14 AU AU2022310346A patent/AU2022310346A1/en active Pending
- 2022-07-14 CA CA3226268A patent/CA3226268A1/en active Pending
- 2022-07-14 JP JP2024501118A patent/JP2024524613A/ja active Pending
- 2022-07-14 CN CN202280060559.6A patent/CN117915956A/zh active Pending
- 2022-07-14 US US18/578,293 patent/US20240335544A1/en active Pending
- 2022-07-14 EP EP22750970.0A patent/EP4370156A1/en active Pending
- 2022-07-14 WO PCT/US2022/037196 patent/WO2023288015A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024524613A5 (https=) | ||
| JP2023512455A5 (https=) | ||
| JP2024524614A5 (https=) | ||
| JP7488003B2 (ja) | 治療において使用するためのスルファミドリンカーを含むバイオコンジュゲート | |
| JP7381478B2 (ja) | 単一分子量ポリサルコシンを含むリガンド－薬物－複合体 | |
| JP5866301B2 (ja) | 増殖及びタンパク質合成の細胞内ターゲッティングのためのポリアニオン性多価高分子 | |
| US8946391B2 (en) | Construction of a multivalent scFv through alkyne-azide 1,3-dipolar cycloaddition | |
| US20230158155A1 (en) | Cell Surface Receptor Binding Compounds and Conjugates | |
| TWI738987B (zh) | 接合單元及包含接合單元之分子構建體 | |
| CN109310765A (zh) | 抗体-药物偶联物 | |
| JP2022512643A5 (https=) | ||
| WO2020145228A1 (ja) | 配位子及びＣＥＡＣＡＭ５抗体Ｆａｂフラグメントからなる複合体 | |
| JP2024524613A (ja) | Ｍ６ｐｒ細胞表面受容体結合化合物及びコンジュゲート | |
| JP2010519182A (ja) | 多量体接合体 | |
| WO2014089247A2 (en) | Modular polymer hydrogel nanoparticles and methods of their manufacture | |
| JP2023529640A (ja) | 治療用コンジュゲート | |
| JP2025186263A (ja) | Ｅｐｉ－ｘ４系ペプチドおよびその誘導体 | |
| JP2019517591A (ja) | αｖβ３インテグリン甲状腺アンタゴニストにコンジュゲートした非開裂性ポリマー | |
| JP2025503512A5 (https=) | ||
| JP2012508231A (ja) | 血管内造影剤 | |
| JP7834363B2 (ja) | トレーサー化合物およびその調製方法 | |
| EP4735443A1 (en) | Cucurbituril derivatives for radiolabeling, processes of production and uses thereof | |
| EP3755381B1 (en) | Optical imaging agents targeting inflammation | |
| JP2026509055A (ja) | Ｍ６ｐｒ結合化合物およびコンジュゲート | |
| WO2022255479A1 (ja) | 中分子化合物の血中動態改善のための中分子化合物コンジュゲート体およびその製造方法 |